ReviewChemistry, an Asian journal2026
Advances in pH-Sensitive Luminescent Transition Metal Complexes for Theranostic Applications.
Review in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
pH sensitive luminescent transition metal complexes are emerging as next generation molecular probes for sensing, bioimaging, and cancer theranostics. Small variations in protonation state can markedly influence their photophysical behavior by modulating charge-transfer processes, excited-state energetics, and noncovalent interactions, resulting in pronounced and often reversible changes in emission intensity or wavelength. In this review, we examine recent advances in the design of pH-responsive luminescent transition metal complexes and discuss the mechanistic origins of their pH sensitivity, including protonation-deprotonation equilibria, hydrogen-bonding effects, and aggregation-induced phenomena. Particular emphasis is placed on ruthenium(II) and related complexes, which offer long-lived excited states, structural robustness, and wide tunability through rational ligand design. We critically analyze representative systems across different metal platforms with respect to their pK
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.